| Serial Number | 97473476 |
| Word Mark | X SCRIBE THERAPEUTICS |
| Filing Date | Thursday, June 23, 2022 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Tuesday, June 11, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, April 25, 2023 |
| Description of Mark | The mark consists of the stylized wordings "SCRIBE" above "THERAPEUTICS", all to the right of a stylized letter "X" partially formed by horizontal lines displayed atop a circle outline. |
| Goods and Services | Pharmaceutical and biological preparations based on genetic engineering and gene therapy for use in diagnosis, prevention, and treatment of diseases in human therapeutics, namely, diseases caused by genetic mutations and diseases and disorders for which gene modification would ameliorate or cure; Gene therapy products, namely, biological preparations based on engineered cells for medical use for the treatment of diseases caused by genetic mutations and of diseases and disorders for which gene modification would ameliorate or cure related to immuno-oncology, degenerative disorders, traumatic injury, enzyme replacement therapy, and immunology; Pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics, namely, for the diagnosis, prevention, and treatment of diseases caused by genetic mutations and of diseases and disorders for which gene modification would ameliorate or cure; Pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders, namely, neurological disorders, Huntington's disease, amyotrophic lateral sclerosis (ALS), front temporal dementia, Alzheimer's, Parkinson's, ataxia, autism, epilepsy, and pain, and also for the prevention and treatment of cardiovascular, peripheral nervous system, endocrine, gastrointestinal, renal, genetic immunological, hepatic, inflammatory, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, respiratory, urogenital, urological, and hematologic diseases and disorders, and cance |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | "THERAPEUTICS" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 12, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Scribe Therapeutics Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Alameda, CA 94501 |
| Party Name | Scribe Therapeutics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Alameda, CA 94501 |
| Event Date | Event Description |
| Monday, June 27, 2022 | NEW APPLICATION ENTERED |
| Tuesday, July 12, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, July 13, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, March 9, 2023 | ASSIGNED TO EXAMINER |
| Thursday, March 16, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, March 16, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, March 16, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, March 16, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, March 16, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 5, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 25, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 25, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 20, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Sunday, December 10, 2023 | SOU TEAS EXTENSION RECEIVED |
| Sunday, December 10, 2023 | SOU EXTENSION 1 FILED |
| Sunday, December 10, 2023 | SOU EXTENSION 1 GRANTED |
| Tuesday, December 12, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, June 11, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, June 11, 2024 | SOU EXTENSION 2 GRANTED |
| Tuesday, June 11, 2024 | SOU EXTENSION 2 FILED |
| Thursday, June 13, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Sunday, December 15, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, January 2, 2025 | TEAS POST PUBLICATION AMENDMENT RECEIVED |